Announced
Completed
Synopsis
Avista Capital-backed United BioSource, a biopharmaceutical company providing integrated clinical, safety, and commercialization services, completed the acquisition of Examoto, a risk evaluation and mitigation strategy company. Financial terms were not disclosed. "We are excited by the compelling opportunities this acquisition presents to expand the industry's leading one-stop-shop for full-service REMS programs. The combination of Examoto's technology-driven approach with UBC's scientific, technological, and operational expertise will ensure the most efficient delivery of successful REMS programs to patients and clients," Patrick Lindsay, UBC President and CEO.
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.